Kolexia
Tardy Brigitte
Biologie médicale
Hôpital Nord CHU Saint-Étienne - Loire
Saint-Priest-en-Jarez, France
77 Activités
16 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hémophilie A Thrombopénie Thrombose Hémophilie B Hémorragie Thrombose veineuse Maladies de von Willebrand Maladies osseuses Myélome multiple

Industries

Sobi
15 collaboration(s)
Dernière en 2023
Aguettant
6 collaboration(s)
Dernière en 2023
A+A
6 collaboration(s)
Dernière en 2022
CSL Behring
5 collaboration(s)
Dernière en 2021

Dernières activités

PHILEOS: Haemophilia and Bone Loss PHILEOS Study
Essai Clinique (CHU Saint-Étienne)   29 décembre 2023
NUAGE: Determination of Normal Values of Parameters of Thrombin Generation in Fresh PRP and in PPP in Function of Different Tissue Factor Concentrations
Essai Clinique (CHU Saint-Étienne)   28 novembre 2023
SENIORHEMO: Objective and Perceived Health Status of Elderly People With Moderate or Severe Haemophilia in France: an Ancillary Study of the FranceCoag Registry
Essai Clinique (Assistance publique - Hôpitaux de Marseille)   07 juin 2023
Obstetrical complications in hereditary fibrinogen disorders: the Fibrinogest study.
Journal of thrombosis and haemostasis : JTH   11 mai 2023
Switch to pdVWF:pdFVIII concentrate for prophylaxis in a paediatric patient with Type 3 von Willebrand disease: a case report.
Hematology (Amsterdam, Netherlands)   06 avril 2023
TRANSHEMO: Determinants and Consequences of the Transition to Adulthood Among Adolescents With Haemophilia - TRANSHEMO
Essai Clinique (Assistance publique - Hôpitaux de Marseille)   13 février 2023
A French Real-World Evidence Study Evaluating the Efficacy, Safety, and Pharmacokinetic Parameters of rVIII-SingleChain in Patients with Hemophilia A Receiving Prophylaxis.
Thrombosis and haemostasis   09 février 2023
Serum D-dimer is not predictive of placenta-mediated complications in pregnancy at high risk: The multicentric prospective cohort AngioPred study.
Frontiers in cell and developmental biology   12 janvier 2023
In Vitro Correction of Thrombin Generation by Concizumab (Anti-TFPI) for Severe Hemophilia Patients: Tissue Factor Pathway Inhibitor (TFPI) and Haemorrhagic Manifestations in Haemophilia A and B Patients
Essai Clinique (CHU Saint-Étienne)   13 décembre 2022
Reinvestigation of unidentified causative variants in FXI-deficient patients: Focus on gene segment deletions.
Haemophilia : the official journal of the World Federation of Hemophilia   04 octobre 2022